您当前的位置:
首页 >
文章列表页 >
Discussion on " inflammation-cancer transformation" of inflammatory bowel disease from the perspective of " deficiency-toxin" theory
Special Theme: TCM Prevention and Treatment of "inflammation-cancer transformation" | 更新时间:2024-10-29
    • Discussion on " inflammation-cancer transformation" of inflammatory bowel disease from the perspective of " deficiency-toxin" theory

    • Journal of Beijing University of Traditional Chinese Medicine   Vol. 47, Issue 10, Pages: 1349-1354(2024)
    • DOI:10.3969/j.issn.1006-2157.2024.10.003    

      CLC: R259
    • Received:23 April 2024

      Published Online:21 August 2024

      Published:30 October 2024

    移动端阅览

  • WEI Xiunan, LIANG Junwei, SUN Dajuan, et al. Discussion on " inflammation-cancer transformation" of inflammatory bowel disease from the perspective of " deficiency-toxin" theory[J]. Journal of beijing university of traditional chinese medicine, 2024, 47(10): 1349-1354. DOI: 10.3969/j.issn.1006-2157.2024.10.003.

  •  
  •  

0

Views

254

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Discussion on the mechanism of the " inflammation-cancer transformation" in primary multiple pulmonary nodules
Analysis of pathogenesis evolution and therapeutic strategies for " inflammation-cancer transformation" in chronic pancreatitis based on " state-target-cause-result"
Analysis on "inflammation-cancer transformation" of chronic gastritis based on the theory of "host-guest interaction"

Related Author

LAI Yuxin
JIANG Liangduo
ZHANG Xiaomei
LI Mengqian
BAI Changchuan
ZHAO Liang
GUAN Xi
XIANG Hong

Related Institution

Dongfang Hospital, Beijing University of Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine
The First Affiliated Hospital of Dalian Medical University
Institute/ College of Integrative Medicine, Dalian Medical University
Liaoning Provincial Center for Integrated Traditional Chinese and Western Medicine Therapy for Biliary and Pancreatic Diseases
0